Skip to main content
. 2010 Jul;24(7):2347–2354. doi: 10.1096/fj.09-149146

TABLE 1.

Functional characterization of the constitutively activating TSHR mutations

Location Transfected construct Ballesteros/Weinstein numbering Cell surface expression: FACS (% TSHR wt) cAMP accumulation
Basal (fold wt) TSH stimulated (% TSHR)
pcDNA3 0 0.3 ± 0.1 ND
wt TSHR 100 1 100
TMH1 V421I 1.39 105.8 ± 8.1 2.1 ± 0.4 85.4 ± 3.1
TMH2 Y466A 2.56 102.3 ± 8.0 2.8 ± 0.5 49.7 ± 7.7
TMH3 T501A 3.32 142.2 ± 9.0 3.4 ± 0.6 128.7 ± 12.8
TMH6 L587V 5.44 89.5 ± 11.0 1.7 ± 0.4 96.6 ± 2.4
TMH6 M637C 6.48 96.1 ± 7.7 2.4 ± 0.6 112.5 ± 24.0
M637W 73.2 ± 6,0 4.8 ± 1.2 101.3 ± 13.1
TMH6 S641A 6.52 74.4 ± 1.8 3.1 ± 0.2 96.8 ± 3.5
TMH6 Y643F 6.54 117.1 ± 10.7 2.1 ± 0.3 88.9 ± 0.1
TMH6 L645V 6.56 82.0 ± 7.2 2.1 ± 0.3 100.4 ± 11.8
TMH7 Y667A 7.42 74.9 ± 3.3 1.7 ± 0.4 85.4 ± 6.9

HEK 293 cells were transfected with the wt TSHR or mutated TSHRs. TSHR cell surface expression level was quantified on a FACS flow cytometer. Receptor expression was determined by the mean fluorescence intensity by comparison to wt TSHR. Data are means ± se of 2 independent experiments, each carried out in duplicate. pcDNA3 vector was used as a control. ND, not determined.